ARMANDO BAZA-VARGAS: Open Payments
NPI 1922087253 · VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 22 payments from 12 companies in 2025. Trend: 2023 $298 · 2024 $471 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| Gilead Sciences, Inc. | 3 | $83 |
| Lilly USA, LLC | 4 | $69 |
| Novo Nordisk Inc | 2 | $43 |
| Boston Scientific Corporation | 1 | $36 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Hologic Sales and Service, LLC | 1 | $18 |
Products named: WaveWriter Alpha Prime 16, MOUNJARO, Wegovy, COBENFY, SHINGRIX, ZEPBOUND, Cologuard Collection Kit, CAPLYTA.
Industry payments across CA — which companies pay providers there.
